Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 RAs in Lymphedema
NCT07012642Phase 1Recruiting
- Sponsor
- Advanced Reconstructive Surgery Alliance
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in lymphedema, sponsored by Advanced Reconstructive Surgery Alliance. Primary endpoint: Lymphedema Life Impact Scale (LLIS) at 6 months. Started Apr 2025; status: recruiting.
02
Conditions
lymphedema
Beyond the preview
Go deeper on NCT07012642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012642.